FDA Warning Letter: Samm Solutions, Inc., d.b.a. BTS Research
Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies. Issued by FDA Center for Drug Evaluation and Research | CDER on 2023-10-20.
FDA Center for Drug Evaluation and Research | CDER
Samm Solutions, Inc., d.b.a. BTS Research